Biofrontera Inc.

BFRINASDAQHealthcare● Active

$0.90

$-0.03(-3.23%)

Market Cap$11523010

P/E Ratio—

52W High$1.19

52W Low$0.555

Avg Volume175K

Open$0.92

Beta0.85

Overview

Biofrontera Inc. (BFRI) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001858685 · BFRI · NASDAQ · as of Jun 9, 2026

Filing snapshot

354

Total Filings

10-Q

Latest Form

2026-05-14

Most Recent

2021

Filing Since

Financials Earnings View All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001858685 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY

Filed Date

2026-03-19

Fiscal Year End

Mar 19, 2026

Accession No.

0001493152-26-011625

Primary Document

form10-k.htm

View on SEC EDGAR Download PDF Filing Index

Source: data.sec.gov · CIK 0001858685 · Accession 0001493152-26-011625

Latest Key Filings

10-QQuarterly Report

10-Q

2026-05-14

View 10-Q on SEC

8-KCurrent Report

8-K

2026-05-14Material Event

View 8-K on SEC

Form 4Insider Activity

Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144

Filed Date

Form Type

Description

View

2026-05-14

10-Q

Quarterly Report

10-Q

0001493152-26-023119

View

10-QQuarterly Report

10-Q

2026-05-14

View

2026-05-14

8-K

Current Report

8-K

0001493152-26-022875

View

8-KCurrent Report

8-K

2026-05-14

View

2026-04-30

DEF 14A

Proxy Statement

DEF 14A

0001493152-26-020616

View

DEF 14AProxy Statement

DEF 14A

2026-04-30

View

2026-03-19

10-K

Annual Report

10-K

0001493152-26-011625

View

10-KAnnual Report

10-K

2026-03-19

View

2026-03-19

8-K

Current Report

8-K

0001493152-26-011545

View

8-KCurrent Report

8-K

2026-03-19

View

2026-03-09

8-K

Current Report

8-K

0001493152-26-009321

View

8-KCurrent Report

8-K

2026-03-09

View

2026-02-26

8-K

Current Report

8-K

0001493152-26-008136

View

8-KCurrent Report

8-K

2026-02-26

View

2026-02-11

SCHEDULE 13G/A

0001622627-26-000005

View

SCHEDULE 13G/ASCHEDULE 13G/A

SCHEDULE 13G/A

2026-02-11

View

2026-02-09

8-K

Current Report

8-K

0001493152-26-005717

View

8-KCurrent Report

8-K

2026-02-09

View

2026-01-28

SCHEDULE 13G/A

0001493152-26-003976

View

SCHEDULE 13G/ASCHEDULE 13G/A

SCHEDULE 13G/A

2026-01-28

View

2026-01-13

8-K

Current Report

8-K

0001493152-26-001959

View

8-KCurrent Report

8-K

2026-01-13

View

2026-01-07

8-K

Current Report

8-K

0001493152-26-000823

View

8-KCurrent Report

8-K

2026-01-07

View

2025-12-19

EFFECT

9999999995-25-003865

View

EFFECTEFFECT

EFFECT

2025-12-19

View

2025-12-05

S-1

IPO Registration Statement

S-1

0001493152-25-026443

View

S-1IPO Registration Statement

S-1

2025-12-05

View

2025-11-13

8-K

Current Report

8-K

0001493152-25-022133

View

8-KCurrent Report

8-K

2025-11-13

View

Showing 1–15 of 310 filingsForm 4 / 144 hidden· 354 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov) | Updated: Hourly | CIK: 0001858685 | Exchange: NASDAQ · Healthcare

Biofrontera Inc. (NASDAQ: BFRI) has submitted 354 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2021. As a Healthcare sector company with CIK 0001858685, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Biofrontera Inc.'s most comprehensive regulatory disclosure. The most recent Biofrontera Inc. 10-K was filed on 2026-03-19 for fiscal year ending 2026. Historical BFRI 10-K annual reports are available from 2021 through 2026.

Investors researching Biofrontera Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09

Related Companies SEC Filings — Healthcare

AYTU SEC Filings →SNSE SEC Filings →COCP SEC Filings →TRIB SEC Filings →IMNN SEC Filings →EVGN SEC Filings →GELS SEC Filings →DWTX SEC Filings →

→ BFRI Financials → BFRI Earnings → BFRI Insider Trades

Frequently Asked Questions

BFRI SEC Filings · 8 questions

Biofrontera Inc. (BFRI) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 354 filings and access original documents at no cost. Biofrontera Inc.'s CIK is 0001858685.

BFRI SEC filingsBiofrontera Inc. SEC documentsfind BFRI 10-K